XML 40 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Comprehensive Loss (unaudited) (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Net income/(loss) including noncontrolling interests $ (10,787,148) $ (6,398,894)
Other comprehensive income (loss)    
Foreign currency translation adjustment (157,447) 734,638
Comprehensive income/(loss) including noncontrolling interests (10,944,595) (5,664,256)
Comprehensive loss attributable to noncontrolling interests 1,088,080 692,660
Comprehensive income/(loss) attributable to Cleveland BioLabs, Inc. $ (9,856,515) $ (4,971,596)